新辅助化疗

  • 网络neoadjuvant chemotherapy;NACT;NCT
新辅助化疗新辅助化疗
  1. 结论NACT后MVD的表达及血清VEGF均明显下降,且与新辅助化疗疗效呈负相关。

    Conclusion The expression of MVD and the level of serum VEGF decreased significantly in patients who react to NACT .

  2. 选择性新辅助化疗是宫颈癌手术治疗有效的辅助治疗措施。

    NACT is a effectual treatment for the operation of cervical cancer .

  3. CT灌注成像评价骨肿瘤新辅助化疗疗效的价值

    CT perfusion imaging for evaluating neoadjuvant chemotherapy in bone neoplasms

  4. 紫杉醇联合卡铂新辅助化疗Ⅱb期宫颈癌50例

    Neoadjuvant Chemotherapy with Paclitaxel and Carboplatin for 50 Cases with Cervical Cancer Stage ⅱ b

  5. MRI在乳腺癌新辅助化疗后行保乳手术中的应用

    Application of MRI in Breast-Conserving Surgery after Neoadjuvant Chemotherapy

  6. 乳腺癌新辅助化疗后血流动力学变化的动态增强MRI研究

    Breast cancer after neoadjuvant chemotherapy : alteration of kinetic characteristics in dynamic contrast-enhanced MR imaging

  7. 新辅助化疗诱导结肠癌细胞凋亡及IκBαmRNA的表达

    Apoptosis of Colon Cancer Cells and Expression of I κ B α - mRNA Induced by Neo-adjuvant Chemotherapy

  8. 新辅助化疗后放射治疗≥N2期鼻咽癌的临床研究

    Neoadjuvant Chemotherapy ( Plus Radiotherapy ) in the Treatment of Patients with N2 Nasopharyngeal Carcinoma - A Randomized Clinical Study

  9. ET方案密集新辅助化疗对乳腺癌治疗的临床疗效观察

    Therapeutic Efficacy of the New Adjuvant Chemotherapy with Dose-dense ET Regime in Breast Cancer

  10. 研究人员对接受新辅助化疗的II期乳腺癌患者进行了研究。

    To investigate , the researchers studied stage II and II breast cancer patients who were receiving neoadjuvant chemotherapy .

  11. Survivin在乳腺癌新辅助化疗中的预期意义

    Predictive significance of survivin in breast cancer response to neoadjuvant chemotherapy

  12. 目的察CAP方案在Ⅲ期乳腺癌术前新辅助化疗的近期疗效及毒副反应。

    Objective Observe the effect and side effect of CAP regimen auxilliary chemotherapy in treating mastocarcinoma ⅲ .

  13. HER-2、p53的表达对乳腺癌蒽环类新辅助化疗疗效的影响

    The Efficacy of Anthracycline-based Neoadjuvant Chemotherapy in Breast Cancer Patients

  14. 新辅助化疗对浸润性膀胱癌预后影响的Meta分析

    Meta-Analysis of effect of adjuvant chemotherapy on prognosis of muscular-invasive bladder cancer

  15. 血清p53抗体检测在乳腺癌新辅助化疗方案制定中的应用研究

    Research for the Application of Detecting Serum Anti-p53 Antibody in the Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

  16. Q值调整的个体化准分子激光角膜屈光手术治疗近视的临床观察新辅助化疗加保肢手术治疗肢体骨肉瘤

    Clinical observation of Q-value guided customized LASIK for myopia The new adjuvant chemotherapy with limb salvage surgery for extremity osteosarcoma

  17. 结果经新辅助化疗后,乳腺癌原发灶明显缩小,11%达到完全缓解(CR);

    Results After neoadjuvant chemotherapy , the primary cancer became smaller , 11 % of them was completely release ( CR );

  18. 新辅助化疗前后PCNA和p53在口腔鳞癌中的表达及其对化疗敏感性的预测研究

    Expression of PCNA and p53 in oral squamous cell carcinoma for prediction of response to neoadjuvant chemotherapy

  19. 术前新辅助化疗在巨块型宫颈癌Ⅰ(b2)~Ⅱb中的疗效观察

    The Therapeutic Value of Preoperative Neoadjuvant Chemotherapy in Patients with Stage ⅰ _ ( b2 )~ⅱ _b Bulky Cervical Cancer

  20. 前言:目的:探讨紫杉醇联合顺铂(TP)对局部晚期宫颈癌新辅助化疗的临床效果。

    Objective : To investigate the effect of TP for neoadjuvant chemotherapy on locally advanced cervical cancer .

  21. 结论胃癌患者存在先天性多药耐药现象,术前检测P-糖蛋白与突变型p53的表达对胃癌的新辅助化疗具有重要的指导作用。

    Conclusion The expression of p53 and P-glycoprotein before operation might be helpful for guidance of chemotherapy in patients with gastric cancer .

  22. 谷胱甘肽对T3期直肠癌新辅助化疗患者的保护作用

    Glutathione Provides Protection for Patients with T3 Stage Rectal Cancer During Neoadjuvant Chemotherapy

  23. 结论ET方案对局部进展期乳腺癌进行新辅助化疗,在肿瘤及淋巴结缩小(降期)效果方面,4周期组明显优于2周期组。

    Conclusion Neo-adjuvant chemotherapy with ET regimen for 4 cycles were more effective than 2 cycles to down staging locally advanced breast cancer .

  24. 目的明确乳腺癌新辅助化疗后动态增强MRI表现强化特征的变化规律。

    Objective To investigate the alteration of kinetic enhancement of breast cancer after neoadjuvant chemotherapy ( NACT ) by dynamic contrast-enhanced MR imaging ( DCE-MRI ) .

  25. CAF短周期密集方案新辅助化疗在乳腺癌中的应用

    The Effect Point of Dose-dense CAF Regime as Short Cycle Neoadjuvant Chemotherapy in Breast Cancer

  26. 新辅助化疗FEC方案和TEC方案对乳腺癌患者的疗效

    Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer

  27. 结论:1.新辅助化疗能有效降低ki-67指数表达,显著抑制肿瘤细胞的增殖活性。

    Neoadjuvant chemotherapy can significantly inhibit tumor cell proliferation by reducing the expression of ki-67.2 .

  28. 肿瘤切除术前的新辅助化疗方案现已成为了肝母细胞瘤(HB)的一项主要治疗手段。

    Neoadjuvant chemotherapy followed by resection has become the mainstay in the treatment of hepatoblastoma ( HB ) .

  29. 新辅助化疗对乳腺癌P-gp、GST-π的影响及意义

    Effects of Neoadjuvant Chemotherapy on P-gp , GST - π Expression in Breast Cancer

  30. 动脉灌注新辅助化疗对大肠癌组织PCNA、VEGF、P53及MVD表达的影响

    Effects of neoadjuvant chemotherapy via arterial infusion on the expressions of PCNA , VEGF , P53 and MVD in colorectal carcinoma